Display options
Share it on

J Renal Inj Prev. 2012 Jan 01;1(1):43-5. doi: 10.12861/jrip.2012.15. eCollection 2012.

Protective effect of high dose short term statin therapy with normal saline in prevention of contrast-induced nephropathy among iodixanol-receiving patients.

Journal of renal injury prevention

Houshang Sanadgol, Siavosh Abdani, Peyman Tabatabaiee, Mehdi Mohammadi

Affiliations

  1. Department of Internal Medicine, Zahedan University of Medical Sciences, Zahedan, Iran.
  2. Faculty of Health, Zahedan University of Medical Sciences, Zahedan, Iran.

PMID: 25340104 PMCID: PMC4205974 DOI: 10.12861/jrip.2012.15

Abstract

Contrast media agents are applied for various diagnostic imagines, however, contrast-induced nephropathy (CIN) limits its usage. Statins have been found to prevent CIN via various mechanisms. However, study regarding the beneficial property of simvastatin as a kind of statin is scarce. This study was aimed to evaluate the efficacy of high dose short term statin therapy against nephrotoxicity of iodixanol. 194 patients were divided equally to control and statin-treated groups. Control group (placebo) received normal satin before and after angiography and statin-treated patients received simvastatin (80 mg/day) plus normal saline before and after angiography. Simvastatin and normal saline were started 12 hours before to 12 hours after the procedure, and serum creatinine before and two consecutive days after procedure were assessed. Estimated glomerular filtration rate (eGFR) was calculated using modification of diet in renal disease (MDRD ) method. In the first 24 hours after procedure, there was no difference between two groups, however after 48 hours of treatment, a significant difference for eGFR between two groups with more values in statin treated group was observed (p=0,002). Prophylactic administration of statins along with hydration may be associated with less contrast-induced nephropathy.

Keywords: Contrast-induced nephropathy; Renal failure; Statin

References

  1. J Cardiovasc Pharmacol Ther. 2011 Sep-Dec;16(3-4):376-9 - PubMed
  2. Toxicology. 2007 Feb 12;230(2-3):256-64 - PubMed
  3. Clin Chem. 2003 Jul;49(7):1223-5 - PubMed
  4. Oxid Med Cell Longev. 2012;2012:831748 - PubMed
  5. Am J Cardiol. 2009 Aug 15;104(4):519-24 - PubMed
  6. Dtsch Med Wochenschr. 2013 Apr;138(14):715-8 - PubMed

Publication Types